
Publikationen von Markus Krumbholz
Alle Typen
Zeitschriftenartikel (26)
2012
Zeitschriftenartikel
209 (3), S. 521 - 535 (2012)
Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration. Journal of Experimental Medicine
Zeitschriftenartikel
22 (5), S. 607 - 618 (2012)
Prospects of transcript profiling for mRNAs and microRNAs using formalin-fixed and paraffin-embedded dissected autoptic multiple sclerosis lesions. Brain Pathology
Zeitschriftenartikel
22, S. 607 - 618 (2012)
Prospects of transcript profiling for mRNAs and microRNAs using formalin fixed and paraffin embedded dissected autoptic multiple sclerosis lesions. Brain Pathology
Zeitschriftenartikel
8 (11), S. 613 - 623 (2012)
B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nature Reviews Neurology
Zeitschriftenartikel
32 (16), S. 1198 - 1207 (2012)
Headache in patients with pituitary adenoma: Clinical and paraclinical findings. Cephalalgia 2011
Zeitschriftenartikel
306 (1-2), S. 180 - 182 (2011)
Humoral autoimmunity in multiple sclerosis. Journal of the Neurological Sciences
Zeitschriftenartikel
76 (15), S. 1310 - 1315 (2011)
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab. Neurology
Zeitschriftenartikel
77 (6), S. 580 - 588 (2011)
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 2010
Zeitschriftenartikel
20 (5), S. 966 - 975 (2010)
Extracellular matrix in multiple sclerosis lesions: Fibrillar collagens, biglycan and decorin are upregulated and associated with infiltrating immune cells. Brain Pathology
Zeitschriftenartikel
30 (4), S. 413 - 424 (2010)
Headache in patients with a meningioma correlates with a bone-invasive growth pattern but not with cytokine expression. Cephalalgia 2009
Zeitschriftenartikel
106 (20), S. 8302 - 8307 (2009)
Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proceedings of the National Academy of Sciences of the United States of America
Zeitschriftenartikel
132, S. 3342 - 3352 (2009)
MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain
Zeitschriftenartikel
15 (6), S. 623 - 625 (2009)
Netting neutrophils in autoimmune small-vessel vasculitis. Nature Medicine 2008
Zeitschriftenartikel
131, S. 1455 - 1463 (2008)
Interferon-β increases BAFF levels in multiple sclerosis: Implications for B cell autoimmunity. Brain
Zeitschriftenartikel
71 (17), S. 1350 - 1354 (2008)
Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Neurology
Zeitschriftenartikel
274 (1-2), S. 42 - 44 (2008)
Compartmentalization of inflammation in the CNS: A major mechanism driving progressive multiple sclerosis. Journal of Neurological Sciences 2007
Zeitschriftenartikel
68 (12), S. 958 - 959 (2007)
Multiple sclerosis: Relating MxA transcription to anti-interferon-β-neutralizing antibodies. Neurology
Zeitschriftenartikel
64, S. 1331 - 1333 (2007)
Delayed allergic reaction to natalizumab associated with early formation of neutralizing antibodies. Archives of Neurology
Zeitschriftenartikel
190 (1-2), S. 72 - 79 (2007)
CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions. Journal of Neuroimmunology 2006
Zeitschriftenartikel
129, S. 200 - 211 (2006)
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain
Zeitschriftenartikel
60 (4), S. 487 - 487 (2006)
B lineage cells in inflammatory central nervous system - Reply. Annals of Neurology
Zeitschriftenartikel
59 (6), S. 880 - 892 (2006)
B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation. Annals of Neurology 2005
Zeitschriftenartikel
159 (1-2), S. 12 - 19 (2005)
Preferential expression and function of Toll-like receptor 3 in human astrocytes. Journal of Neuroimmunology
Zeitschriftenartikel
25 (4), S. 298 - 302 (2005)
BAFF is elevated in serum of patients with Wegener's granulomatosis. Journal of Autoimmunity
Zeitschriftenartikel
201 (2), S. 195 - 200 (2005)
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. Journal of Experimental Medicine
Zeitschriftenartikel
175 (4), S. 2301 - 2308 (2005)
Expression and function of glial cell line-derived neurotrophic factor (GDNF) family ligands and their receptors on human immune cells. Journal of Immunology